![Hero image of one of 7IM's brand shapes in orange and teal](/media/ktdoniho/ifa-hero-03.jpg?mode=crop¢er=0.4541935483870968,0.73166666666666669&width=1920&height=823)
Quarterly Rebalance Commentary
Overview
Our last portfolio rebalance in November 2023 was followed by upbeat and positive sentiment across the market.
Economic data released in November brought optimism back to markets. As inflation showed signs of softening, central banks signalled the end of the hiking cycle, allowing investors to breathe a sigh of relief. This translated into a generous equity market with a month-end gain of 9% in the S&P 500, which marks one of the best November gains in a century for the index. Thanks to the large technology stocks, the Nasdaq 100 also grew almost 11% in the month, up from three consecutive months of losses. Equally, the fixed income market reacted positively to the promise of rate cuts in 2024, and global bonds underwent their fastest surge since the 2008 financial crisis.
The healthy backdrop continued into December, as fixed income and equities maintained their upwards trends. In the bond market, falling yields started providing significant capital gains; for instance, the Gilt maturing in 2061 saw a 25% appreciation in the month. In the equity market, large cap in the US climbed 5%, but with slightly less help from the Magnificent Seven; small cap also shone, proof of which was the Russell 2000 index’s 14% rise. This “Santa Rally” moved all major asset classes into positive territory for the year, a stark reversal of the disappointing returns available for investors in 2022.
In January, economic data continued to convince investors that central banks have reached the end of the rate hike cycle. Data out of the US showed stronger-than-expected GDP growth, and equity markets soared once more, seeing the S&P 500 reach a new all-time high. Meanwhile in Europe the Red Sea disruptions added to an already struggling manufacturing sector and economic growth in China continued to slow, with deflation adding more pressure to the country’s property crisis.
Core investment views
Despite the general optimism, it would be foolish to adopt a fully positive stance at any point in time. Even in a largely positive market, it is important to make sure no stone is left unturned to avoid any surprises on the downside. That is what we’re doing at 7IM - our properly diversified portfolios enable us to grow in every kind of environment:
![August Chart](/media/mn2jj2bw/chart.png)
Tactical Asset Allocation
In an environment with lots of uncertainty and a lack of confidence, we want to make sure portfolios are insulated against shocks, while still generating sufficient returns to make investing worthwhile. And we think our portfolios are set up to do just that.
![Rebal Comm Table Feb 2024](/media/1xeltvvo/rebal-comm-table-feb-2024.png)
Portfolio positions
There’s no one answer… When managing a diversified long-term portfolio, there shouldn’t be a single ‘big’ call. For an outlook which calls for selectivity, especially in the medium and short term, we’re finding lots of different opportunities – both to protect capital and to grow it.
Long term: Thematic | |
---|---|
Healthcare companies | Stable earnings when others are seeing uncertainty |
Climate transition leaders | Uncorrelated to short-term economic cycle |
Alternatives | Defensive and diversifying |
Metal & mining companies | Cheap and stable businesses. Short-term volatility, but profitable long-term |
Medium term: Opportunities | |
---|---|
Finding pockets of value in the US | Investing in the most dynamic parts of the US economy |
Tilt to UK Large Cap | Reduce domestic UK exposure while the economic uncertainty remains |
AT1s | Attractive returns from here |
Short term: Portfolio risk appetite | |
---|---|
Underweight equity risk | Reduce equity exposure as returns will be limited for the time being |
Overweight bond duration | Bonds can do well if inflation continues to fall |
Asset allocation changes
We have made the following tactical changes to portfolios in this quarterly rebalance:
• Small reduction in our Government Bond allocation, but remain overweight compared with our SAA.
• Reduction in our Healthcare Innovations position. This is a position we still like for the growth potential it adds to portfolios, but after positive returns this quarter, we are rotating into other parts of the market.
• Added some FTSE 250 exposure back into portfolios. Having favoured focussing on the larger cap FTSE 100 part of the UK market, this quarter we moved some of this allocation back into the mid-cap space.
Manager changes
This quarter, there was one new addition to portfolios:
• iShares Japan Equity ESG Index Fund has been added to blended mandates as part of the continued effort to decarbonise strategic allocations while managing risks associated with poor governance and sustainability.
• L&G UK Mid Cap Index Fund was brought into portfolios. This provides exposure to the FTSE 250 section of the UK equity market.
Please note: All of the comments on this page refer to the models we run on the 7IM platform, but the models are also available on a range of other platforms. As much as possible, we try to replicate the models we run of the 7IM platform across all platforms, but due to differing security availability, not all of the points outlined in this document may be relevant across these platforms. If you are unsure whether certain changes apply to models on a specific platform, please reach out to a member of the team.
You can download the commentary as a PDF here.
![7IM Intermediary brand shape image 9](/media/nayotxao/ifa-feature-09.jpg?mode=crop¢er=0.5,0.5&width=1000&height=620)
![7IM Intermediary brand shape image 3](/media/22scin4y/ifa-feature-03.jpg?mode=crop¢er=0.5,0.5&width=1000&height=620)
![One of 7IM's brand shapes in orange and teal](/media/mq3fpxmv/q4-2023.png?mode=crop¢er=0.51665022779578229,0.75166666666666671&width=1000&height=620)